Yue K. Luo
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Intratumoral Brevibacillus parabrevis enhances antitumor immunity by inhibiting NK cell ferroptosis in hepatocellular carcinoma.
Journal: Cell death & disease
Published: January 21, 2025
Short-term starvation inhibits CD36 N-glycosylation and downregulates USP7 UFMylation to alleviate RBPJ-maintained T cell exhaustion in liver cancer.
Journal: Theranostics
Published: January 16, 2025
New mechanistic understanding of FXR agonist Vonafexor: inducing sublethal damage of HBV-positive liver cancer cells via promoting anti-tumor immunity.
Journal: British journal of cancer
Published: August 01, 2024
PPARα suppresses growth of hepatocellular carcinoma in a high-fat diet context by reducing neutrophil extracellular trap release.
Journal: JHEP reports : innovation in hepatology
Published: July 12, 2024
Hypoxia-responsive lncRNA MIR155HG promotes PD-L1 expression in hepatocellular carcinoma cells by enhancing HIF-1α mRNA stability.
Journal: International immunopharmacology
Published: April 25, 2024
LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2-macrophage infiltration through activating AKT-IKKβ-p65 axis.
Journal: Molecular carcinogenesis
Published: February 24, 2024
Single-cell atlas reveals characteristic changes in intrahepatic HBV-specific leukocytes.
Journal: Microbiology spectrum
Published: November 30, 2023
Correction to: A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: November 16, 2023
A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: July 28, 2023
Last Updated: 09/26/2026